Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SNL BioSolutions ApS
APS
Active
CVR 44569272
Hagens Alle 7, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SNL BioSolutions ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-2M
2024
-1M
2025
EBITDA
DKK millions
0M
-1M
-3M
-4M
-5M
-4M
2024
-2M
+50%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
-1.543
-607
Staff expenses
-2.142
-1.649
EBITDA
-3.685
-2.256
Depreciation & amort.
-0
-11
EBIT
-3.685
-2.267
Net financials
-211
-228
Profit before tax
-3.896
-2.495
Tax
-0
-738
Net profit
-3.896
-1.756
Balance sheet
DKK thousands
Item
2024
2025
Total assets
881
671
Equity
-3.850
-4.707
Long-term debt
4.620
4.851
Short-term debt
111
527
Total debt
4.731
5.378
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-225582600.0%
This company
2024
2025
Equity ratio
-701.0%
This company
38.2%
Market median
-1935% vs market
2024
2025
Return on equity
-175647500.0%
This company
18.4%
Market median
-954606078% vs market
2024
2025
Net profit margin (of gross profit)
-175647500.0%
This company
2024
2025
Asset turnover (of gross profit)
-0.90×
This company
2024
2025
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-17 – 2024-12-31
View
PDF
More on SNL BioSolutions ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
